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 Introduction  
The global burden of HIV and tuberculosis  
Human Immunodeficiency Virus (HIV) has been recognised as one of the most devastating 
epidemics in recent history, since it was first recognised in the 1980’s 1. The number of people 
living with HIV (PLHIV) in 2016 was estimated at 36.7 million, with 1.8 million new infections 
and 1 million Acquired Immune Deficiency Syndrome (AIDS) related deaths recorded 2. 
Resource-limited countries are more affected, with the majority of PLHIV from Sub-Saharan 
Africa (64%) 2. In recent years, the overall global trend related to an increased HIV prevalence 
alongside a substantial decline in AIDS-related deaths 3. These trends are largely attributable 
to the increased use and availability of anti-retroviral medications 3.  
Tuberculosis is as devastating and has been proven to be one of the top 10 causes of death 
worldwide 4. In 2017 alone, an estimated 10 million people developed tuberculosis, whereas 
1.6 million people died from tuberculosis (1.3 million HIV-negative and 300 000 HIV-positive) 
4. Currently, 23% of the world’s population (about 1.7 billion people) are estimated to have 
latent tuberculosis infection and are therefore at risk of developing active tuberculosis disease 
during their lifetime 4. Increased awareness and access to antituberculosis medication has 
resulted in a steady decline in the global absolute number of tuberculosis deaths in both HIV-
negative and HIV-positive people 4.  
HIV and tuberculosis co-infection is often seen as a lethal combination, causing numerous 
diagnostic and therapeutic challenges in affected individuals 5. A complex but well described 
relationship exists between HIV and tuberculosis - the more advanced the degree of 
immunodeficiency, the higher the risk of contracting tuberculosis 6,7. Tuberculosis still remains 
one of the leading causes of HIV-associated morbidity and mortality worldwide, affecting both 
adults and children 8. In 2017, 300 000 of 940 000 (32%) HIV deaths, globally, occurred among 
people co-infected with HIV and tuberculosis; this has shown a decline in recent years 9. 
However, many cases of tuberculosis in PLHIV are only diagnosed post-mortem at autopsy, 
which suggest that tuberculosis-related HIV deaths may be even more prevalent 10. On a global 
scale, an equivalent of 12% of patients with notified tuberculosis disease had a documented  
HIV positive result in 2017, of which the highest burden (72%) was accounted for by the World 
Health Organization (WHO) African region 4. Despite increased access to anti-retroviral 
treatment (ART) and improved life expectancy in recent years, HIV prevention strategies and 
education remain insufficient, with no known cure as yet 11.  
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The South African HIV and tuberculosis burden and relevance  
Sub-Saharan Africa accounts for about 71% of the global HIV burden, yet only houses about 
12% of the world’s total population 3.  
The incidence and mortality of tuberculosis in South Africa appear to be declining, as a result 
of increased awareness and the use of anti-tuberculosis medications. This decline is regrettably 
not fast enough to meet the 2030 Sustainable Development Goals or the 2035 End TB Strategy 
targets 12. In order to meet these targets, the WHO estimates that by 2030, tuberculosis 
incidence rates for South Africa would need to decrease to 167 per 100 000 population and 
decrease to 83 per 100 000population by 2035 12. There were an estimated 454 000 incident 
tuberculosis cases in South Africa in 2015, at a rate of 834 cases per 100 000 population, with 
the highest global burden of HIV co-infection 1. South Africa is also on the WHO’s list of the 
top 20 highest estimated number on incident tuberculosis cases in the world 4 and is one of six 
countries accounting for 60% of the global tuberculosis burden 12.  
Late presentation and non-diagnosis of tuberculosis and HIV  
Many patients in South Africa still do not know their tuberculosis or HIV status, despite 
extensive rollouts of tuberculosis and HIV prevention plans and allocated financial resources 
13,14. Multiple factors attribute to this, including stigmatisation, long waiting times at healthcare 
facilities, denial, and fear of discrimination 15,16. These patients are often only diagnosed late 
in their disease course, some patients not even at all, and do not obtain the full benefit from 
available treatment and HIV/tuberculosis care services 16. The presence of HIV infection often 
complicates the clinical presentation of active tuberculosis, particularly in patients with 
advanced immunocompromised states 17. Such patients may present with little to no symptoms 
of active tuberculosis, non-specific symptoms only (fatigue, weakness, anaemia) and decreased 
specificity of diagnostic testing (normal appearance on chest x-rays, smear-negative sputum 
results), thus leading to diagnostic inaccuracy and delayed diagnosis 17. It is well established 
that delay in diagnosis and treatment of these conditions result in increased morbidity, 
economic loss to the patient, increasing numbers of emergency presentations and an increased 
mortality 12,18-20.  
HIV and tuberculosis-related emergencies  
Disease burden and morbidity is mainly dictated by disease prevalence. South Africa is 
currently facing the crisis of a quadruple burden of disease, which seem to be more prevalent 
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in the socio-economically deprived regions, where resources are limited and education is 
lacking 21. In resource limited settings with a high HIV prevalence, medical emergencies related 
to tuberculosis and HIV frequently presents to emergency care facilities, especially in more 
advanced disease states 22. Such individuals are thus more susceptible to severe (often 
opportunistic) infections involving multiple organ systems, including involvement of the 
respiratory tract, cardiovascular-, gastrointestinal- and central nervous systems. Frequent HIV 
and/or tuberculosis-related presentations to emergency centres include systemic septicaemia, 
pneumonia, meningitis, thrombo-embolic phenomena (deep vein thrombosis and pulmonary 
embolism), massive haemoptysis, acute respiratory distress syndrome (ARDS), acute and 
chronic gastroenteritis, encephalopathy and pericardial disease 22-25. Unique patterns of disease 
are also encountered in HIV-positive individuals, such as HIV-related chronic kidney disease 
(HIVAN), cardiomyopathies and neuro-cognitive disorders 26–28. Clinicians require high level 
of suspicion, time to investigate patients adequately and knowledge of these potential 
complications to make accurate diagnoses in high-risk patients.  
Anti-retroviral therapy and anti-tuberculosis treatments are also associated with numerous and 
potentially life-threatening side effects. Immune-reconstitution inflammatory syndrome (IRIS), 
cutaneous adverse drug reactions (e.g. Steven Johnson syndrome and toxic epidermal 
necrolysis), and drug induced liver injury (DILI) have been well described in the literature and 
are frequently encountered in high prevalence settings 29–31.  
Diagnosis and management of HIV and tuberculosis related emergencies require knowledge of 
the diseases’ pathophysiology, an appropriate rapid assessment and early initiation of 
treatment. Adequate resources should also be available to ensure effective and efficient care 23.  
The South African healthcare system and the distribution of resources  
South Africa’s healthcare system is often said to be fragmented and unequal, with numerous 
challenges and few solutions 32.  It consists of a large public sector (serving approximately 82% 
of the country’s population), a smaller private sector that is largely funded by subscriptions of 
patients to medical aid schemes or private paying patients, and non-government organisations 
(NGOs) 33. Wealthier citizens are thought to enjoy the benefits of world class healthcare with 
the luxury of timeous consultations, better facilities and improved infection control measures 
34. The South African district health system has 52 districts among its 9 provinces 12, with 4200 
public primary health-care facilities which provide health care equivalent to 1 facility per 13 
718 people, exceeding current WHO guidelines of 1 facility to 10 000 people 33. This reflects 
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the major burden of healthcare and disease that is placed on the public health system, along 
with issues of limited resources, shortage of healthcare professionals and poor infrastructure  
33.  
Emergency centres/emergency care capacity  
At the heart of every hospital is the emergency centre and forms the direct point of entry to 
patients in need of emergency care 35. The emergency centre is defined as a dedicated area 
within a health facility, providing services 24 hours a day, equipped with facilities and 
resources to provide a high standard of emergency care to community members who require 
acute or urgent care 35. The emergency centre is typically the busiest and most unpredictable 
of all hospital departments, seeing a vast range of presenting complaints from patients of all 
ages and degrees of health. The urgency with which patients are to be seen and assessed is 
determined by the South African Triage Scale (SATS) 36, which categorises patients into colour 
coded groups according to their presenting complaints and vital signs. Each colour code has 
suggested waiting times for patients to be seen and assessed. The triage colour codes and 
waiting times are as follows: 36  
• Red (emergency) to be seen immediately  
• Orange (very urgent) to be seen in under 10 minutes  
• Yellow (urgent) to be seen in under 1 hour  
• Green (non-urgent) to be seen in under 4 hours  
• Blue (deceased) to be certified by doctor in under 2 hours  
It is not always possible for facilities to keep to these recommended time frames, depending on 
patient load and health care provider availability 37. This suggests that emergency centre 
capacity for urgent care is often outweighed by limited human and physical resources. Another 
additional problem that the emergency centre often faces is patients presenting with complaints 
that can be dealt with at primary health care (PHC) level, usually with a green triage score 38–
41. Multiple factors can attribute to this, including long waiting times at PHC facilities, patient 
perception that care is better at bigger hospitals and lack of after hour services 42.   
Every emergency centre is required to have a resuscitation area, usually reserved for patients 
requiring immediate assessment and often life-saving interventions 35. Although no strict 
universal criteria exist for patients to be admitted to or managed in a resuscitation area, it is 
generally accepted that the most critically ill and injured patients receive treatment there, 
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determined by either a high SATS acuity score or at the discretion of a senior clinician 36, taking 
into account individual facility’s resources and protocols.   
The HIV and tuberculosis burden on the emergency centre  
Limited data is available on disease burden specific to the resuscitation area, however one study 
has described a case mix of patients managed in a district level resuscitation area, including 
trauma and medical emergencies. HIV featured as the most commonly presenting comorbidity 
(23%), but this figure may not be a true reflection of the actual HIV burden, as HIV is not 
routinely tested for or documented in trauma-related cases 43.   
A 2014 study in Botswana analysed presentations to a tertiary level emergency centre where 
the majority of presenting complaints were infection related. This study, however, did not 
elaborate on the kind of infections treated; even though the country has a high HIV prevalence, 
neither tuberculosis nor HIV specific infection was described, and the authors often grouped 
multiple infective pathologies into one category 44. The study also did not specify in which area 
of the emergency centre these patients were seen or treated.   
The feasibility of point-of-care HIV testing in the emergency centre has been shown in a 
Ghanaian study in 2014, where the prevalence and proportion of emergencies co-morbid with 
HIV were not accurately characterised. Patients presenting to the emergency centre for various 
reasons were offered rapid HIV testing; 41% of patients declined. The prevalence of HIV as a 
comorbidity was described in 13.5% of patients who had consented to HIV testing, compared 
to the national prevalence of 1.4% at the time 45. This may reflect differences in health seeking 
behaviour or lack of HIV testing amongst the general population. The study assessed the 
association of certain variables (education level, religion, occupation, marital status) and 
presentations with HIV, but did not analyse tuberculosis status or the burden of HIV on specific 
areas of the emergency centre.  
The need to obtain a deeper insight into the HIV/tuberculosis burden on district level hospitals 
in South Africa, particularly in regions with high disease prevalence, is especially important to 
improve health care education and allocate resources in the country. There is very little 
published research on the ability of South African emergency centres to deal with this 
pandemic, however, a study conducted at a district level emergency centre in KwaZulu-Natal 
(where the HIV prevalence is the highest in the country) has shown some considerable insight. 
The prevalence of HIV in the sample of patients who presented to the emergency centre was 
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noted to be considerably higher than the South African national prevalence (50% vs 17.9% in 
2012), with approximately 37% of patients not having a confirmed or known HIV diagnosis. 
Respiratory pathology was the leading cause of presentation to the emergency centre, and 
tuberculosis on top of the list of causes of mortality 46. Even though the study did not focus on 
the resuscitation area of the emergency centre, and findings not generalisable to the rest of the 
South African district health care services, it serves as a good starting point for further and 
more specific research into the burden of HIV and tuberculosis on emergency care services.  
Conclusion  
There is a general paucity of data available for cases managed in resuscitation areas in South 
Africa, particularly relating to the HIV and tuberculosis burden. Even though South Africa has 
taken major strides to tackle this double-edged sword, the true disease burden and impact on 
district level settings still needs to be determined in order to ascertain the level of resources 
(human and material) required to treat these patients. Late and misdiagnosis of HIV and 
tuberculosis may be prevented with point-of care testing if offered to patients presenting for 
treatment to emergency centres, possibly leading to earlier initiation of treatment and reduction 
in emergency complications and presentations of these disease entities. A higher level of 
clinical suspicion and time for investigation is required with high risk patients, which is not 
often afforded in the busy and overpopulated emergency centre setting. As HIV and 
tuberculosis are not issues that are likely to be resolved in our lifetime, it is important to gain 
more knowledge and insight into this arena to improve quality of care, adequate supply and 
utilisation of resources at district level hospitals.  
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Abstract  
Introduction  
Many patients present to emergency centres with HIV and tuberculosis related emergencies. 
Little is known about the influence of HIV and tuberculosis on the resuscitation areas of 
district-level hospitals. The primary objective was to determine the prevalence and in-hospital 
mortality of patients with HIV and/or tuberculosis presenting to the resuscitation area of 
Khayelitsha Hospital, Cape Town.  
Methods  
A retrospective analysis was performed on a prospectively collected observational database. A 
randomly selected 12-week sample of data was used. Trauma and paediatric (< 13 years) cases 
were excluded. Patient demographics, HIV and tuberculosis status, disease presentation, 
investigations and procedures undertaken, disposition and in-hospital mortality were assessed. 
HIV and tuberculosis status were determined by laboratory confirmation or from clinical 
records. Descriptive statistics are presented and comparisons for categorical data were done 
using the χ2-test.  
Results  
A total of 370 patients were included. HIV prevalence was 38.4% (n=142; unknown status 
n=78, 21.1%) and tuberculosis prevalence 13.5% (n=50; unknown status n=233, 63%). The 
HIV/tuberculosis coinfection rate was 10.8%. Age (mean 42.5 years) and gender distribution 
(male 40.3%) were similar amongst HIV and tuberculosis groups. Intentional overdose 
presentations were more frequent in the HIV positive group (14.8% vs 8.7%, p<0.01). HIV-
negative patients were less likely to receive an abdominal ultrasound examination (p<0.01) to 
aid in excluding extra-pulmonary tuberculosis and received less intravenous antibiotics 
(p<0.01). In-hospital mortality was 17% and was not influenced by HIV status (p=0.27) or 
tuberculosis status (p=0.27).  
Conclusion  
This study highlights the influence of both HIV and tuberculosis on the resuscitation area of a 
district level hospital. Neither HIV nor tuberculosis status were associated with in-hospital 
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mortality. The high prevalence of intentional overdose may reflect underlying social concerns 
that need to be addressed.  
  
Keywords: Emergency Centre; HIV; Tuberculosis; Prevalence; In-hospital mortality  
    
Introduction  
The Human Immunodeficiency Virus (HIV) poses a substantial healthcare burden on a global 
scale, particularly in socio-economically deprived regions.1 In 2018, approximately 37.9 
million people were living with HIV, with an estimated 1.7 million becoming newly infected 
and 770 000 dying from AIDS (Acquired Immunodeficiency Syndrome) related illnesses.2 
Sub-Saharan Africa accounts for almost 70% of the global HIV incidence, with South Africa 
being one of the top 10 countries contributing to the burden.3 In 2017, South Africa’s HIV-
prevalence was 12.6% (7 million people),4 while the Western Cape had an HIV prevalence of 
6.6% in 2015/2016 (incidence 19 396 per 100 000 population).5 HIV was also associated with 
6.1% (n=3061) of all deaths in the Western Cape in 2015.6  
Tuberculosis (pulmonary and extra-pulmonary) adds a similar burden. An estimated 10.4 
million people were diagnosed globally with tuberculosis in 2016, with 25% of cases reported 
from the World Health Organization African region.1 In the same year, the South African 
tuberculosis incidence was 520 per 100 000 persons, with a Western Cape incidence of 681 per 
100 000 population.7  
Globally, in 2015, 1.2 million patients with tuberculosis (11%) were also found to be HIV 
positive.8 Fifty seven percent of South Africans with tuberculosis had a documented HIV-
positive status in 2016,7 with 39% of all newly diagnosed tuberculosis patients in the Western 
Cape being HIV-positive.7  
The prevalence of HIV and tuberculosis related emergencies is dictated by disease prevalence, 
the availability of treatment and the expertise of the health care system. HIV infection is also 
associated with non-tuberculosis related complications. Serious and possibly life-threatening 
complications can relate to the respiratory system (bacterial pneumonia, Pneumocystis jiroveci 
pneumonia), the cardiac system (pericardial disease, cardiomyopathy) and the neurological 
system (cryptococcal meningitis, toxoplasmosis),9 but essentially any organ system can be 
involved.  
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Patients with HIV and tuberculosis are able to access HIV and anti-tuberculosis treatment via 
numerous primary health care institutions across South Africa.10 However, many of these 
patients still present to emergency centres, particularly with HIV and tuberculosis related 
emergencies. There is a perception amongst health care personnel that patients with HIV and 
tuberculosis place a large burden on the emergency centre.11 Despite studies conducted within 
emergency centres in South Africa and the Western Cape, no studies have specifically 
described the burden of HIV and tuberculosis within emergency  
centres.12–14  
The primary objective of this study was to determine the prevalence of HIV and tuberculosis 
in patients presenting to the resuscitation area of the Khayelitsha Hospital. The secondary 
objective was to determine the association of HIV and tuberculosis status to in-hospital 
mortality.  
Methods  
Study design  
A retrospective analysis was performed on a prospectively collected observational database. A 
supplementary chart review was performed to include additional variables and to limit missing 
data.  
Setting  
Khayelitsha Hospital is a 300-bed district-level hospital situated in the constantly expanding 
informal settlement of Khayelitsha, Cape Town.15 It services a large, socio-economically 
challenged health district (population > 500 000 people) with high levels of unemployment 
(38%), interpersonal violence, and a high disease burden of tuberculosis and HIV.16 The 
hospital provides in- and outpatient medical, surgical, paediatric and obstetric services. There 
is also an emergency centre that manages approximately 35 000 patients per annum with an 
admission rate of about 30%. The emergency centre is 30% larger than for a standard district 
level hospital in South Africa,15,16 with a five-bed (including one paediatric cot) dedicated 
resuscitation area. The area is equipped with monitoring devices (blood pressure, pulse 
oximetry, capnography, etc.) and acute capabilities for airway management, ventilation and 
defibrillation. It is the only area outside of the operating theatre where patients can be 
continuously monitored, as the hospital has no high care or intensive care facilities. The main 
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admission criteria to the resuscitation area is based on a high acuity score according to the 
South African Triage Scale,17 or at the discretion of the senior medical practitioner on duty.  
Study population and sampling strategy  
The electronic Khayelitsha Hospital Emergency Centre database is an ongoing, prospectively 
collected observational database and has previously been described.13 Data are captured 
electronically, immediately coded and stored onto a password protected server, with a 
separately stored decoding sheet.  
A randomly selected 12-week sample (obtained between 1 November 2014 and 16 August 
2015) was obtained from the database, using a computer-based random number generator. The 
12-week sample of data was deemed sufficient to fulfil the requirements of the pre-determined 
objectives of the study, while also considering time and resource constraints.  All patients 
admitted to the resuscitation area during this time period were eligible for inclusion, with 
exception of paediatric (< 13 years) and trauma related cases.  
Data collection  
Data have been collected by the investigators on site after a decoded, cleaned extract of the 
electronic database was obtained (cleaned: copied onto an Excel spreadsheet with all trauma 
and paediatric cases removed). The password protected Microsoft Excel® spreadsheet was then 
further populated by reviewing patients’ electronic clinical records. Laboratory results not 
documented in the patient records were added by accessing the National Health Laboratory 
Service (NHLS) web view. NHLS data were double checked using patient name and date of 
birth to include results from all public health facilities that the patient may have attended.  
Variables collected include patient demographics (age, gender), tuberculosis status (and 
treatment status if indicated), and HIV status (including CD4 lymphocyte count and 
antiretroviral use if HIV-positive). Patient acuity was measured using the South African Triage 
Scale, which categorises patients as Emergency (Red), Very urgent (Orange), Urgent (Yellow), 
and Non-urgent (Green).17 Data relating to patient’s stay in the resuscitation area included 
admission category, diagnostic tests performed, interventions received, disposition from and 
time spent in the resuscitation area. Admissions were categorised based on physiologic systems 
involved (e.g. cardiovascular, gastro-intestinal, respiratory etc.) as opposed to the final clinical 
diagnosis or disease process. The all-cause in-hospital mortality of patients was also collected.  
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An HIV-positive case was defined as a laboratory confirmed result (either prior to admission 
or during the admission). Patients with an unknown HIV status were reported and analysed as 
such. An active tuberculosis case was defined as laboratory confirmed result from any clinical 
specimen during the current admission, six months prior to admission, six months after 
admission, or patients who have been empirically diagnosed with active tuberculosis and 
started on anti-tuberculosis treatment. These results have been verified on the NHLS web view 
using the patient’s folder number, initial and surname, or date of birth as filter criteria. Patients’ 
clinical response to anti-tuberculosis treatment was not assessed. This is usually done at the 
primary health care level, and the emergency centre does not have access to these records. 
Patients were only tested for tuberculosis and /or HIV on clinical suspicion of the treating 
physician if the result was to affect the clinical management or outcome of the presenting 
complaint and not as a routine investigation. Additional investigations for tuberculosis included 
abdominal ultrasound (either as point-of-care by treating doctors or formal scans performed by 
radiographers).  
Data analysis  
Analysis was done using Microsoft Excel® and SPSS Statistics for Windows, Version 25.0 
(IBM Corp. Released 2017. Armonk, NY: IBM Corp.). Patients with incomplete information 
have been excluded from analysis for those variables where information was missing. Summary 
statistics have been used to describe all variables. Distributions of variables are presented with 
frequency tables. The prevalence of HIV, tuberculosis and HIV/tuberculosis co-infection was 
calculated using the total number of patients in the sample as the denominator. The denominator 
for HIV and tuberculosis categories only included patients of whom the status could be 
determined as described above (i.e. unknown status was excluded). Data were categorized into 
four nominal variables to enable the comparison of in-hospital mortality: i) No active 
tuberculosis and HIV-negative, ii) No active tuberculosis and HIV-positive; iii) Active 
tuberculosis and HIV-negative, and iv) Active tuberculosis and HIV-positive. Pearson’s χ2-test 
or Fisher’s exact test were used for comparing proportions, and the independent samples t-test 
to compare medians. A 5% significance level was applied.  
Ethical considerations  
The study has been approved by the Stellenbosch University Health Research Ethics 
Committee (Ref: S15/10/243). The database from which the initial data was drawn is registered 
with the Stellenbosch University Health Research Ethics Committee (Ref: N14/08/102) as well 
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as on the National Health Research Database (Ref: WC_2014RP10_967). A waiver of informed 
consent was granted.  
    
Results  
A total of 370 patients were analysed (Figure 1).  
  
  
aHuman Immunodeficiency Virus;  bTuberculosis  
Figure 1.Flow diagram depicting study population  
  
The prevalence of HIV was 38.4% (n=142) (unknown status: n=78, 21.1 %), with only 48.6% 
(n=69) of HIV-positive patients receiving anti-retroviral therapy (defaulted n=8, 5.6%; 
unknown if on treatment n=31, 21.9%). The median absolute CD4 count was 230 cells/µL (25th 
– 75th percentile 61 to 420) in the 95 patients who had a documented absolute CD4 count.  
The prevalence of tuberculosis was 13.5% (n=50), although the majority of patients (n=233, 
63%) did not had any investigations to exclude or confirm a diagnosis of tuberculosis. Forty-
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four patients (88%) with active tuberculosis received treatment; four (8%) patients did not 
receive treatment while in hospital (treatment status unknown n=2, 4%). The HIV/tuberculosis 
co-infection prevalence was 10.8% (n=40).  
The median age of patients was 40 years (25th – 75th percentile 28 to 56) with HIV and 
tuberculosis more likely in younger patients (Table 1). The acuity of most patients were at least 
very urgent (n=245, 66.2%).  
  
Table 1. Patient demographics and acuity according to HIV and tuberculosis status in patients 
managed in the resuscitation area of Khayelitsha Hospital     
  Overall 
(N=370)  
HIV- 
positive  
(n=142)  
HIV- 
negative  
(n=150)  
p- 
value  
Tuberculosis 
confirmed  
(n=50)  
Tuberculosis 
not confirmed  
(n=87  
p- 
value  
Age (years) 
(Median(Q1Q3a ))  
40 (28-
56)  
36 (29-45)  46 (28-64)  0.001  36 (30-45)  49 (34-68)  0.001  
Male n (%)  
149 
(40.3)  
42 (29.6)  75 (50.0)  <0.001  22 (44.0)  44 (50.6)  0.42  
Time spent in area  
(minutes) (Median (Q1-
Q3))  
270 
(135- 
480)  
289 
(145- 
500)  
285 
(135- 
480)  
0.957  380 (240-730)  287 (182-483)  0.021  
Patient acuityb   
n (%)  
              
 -  Non-urgent  
(Green)  
64 (17.3)  19 (13.4)  22 (14.7)  0.734  3 (6.0)  10 (11.5)  0.535  
 -  Urgent  
(Yellow)  
61 (16.5)  24 (16.9)  25 (16.7)  0.987  8 (16.0)  14 (16.1)  0.966  
-  Very urgent 
(Orange)  
113 
(30.5)  
48 (33.8)  42 (28.0)  0.3  17 (34.0)  33 (37.9)  0.61  
 -  Emergency  
(Red)  
132 
(35.7)  
51 (35.9)  61 (40.7)  0.445  22 (44.0)  30 (34.5)  0.292  
aQ1-Q3= 25
th – 75th percentile; bAccording to the South African Triage Scale  
  
The most frequent admissions to the resuscitation area during the study period involved 
intentional overdoses (n=60, 16.2%), the respiratory system (n=59, 15.9%) and the neurology 
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system (n=50, 13.5%). Intentional overdose and gastro-intestinal related admissions occurred 
more in the HIV-positive group (Table 2).  
  
  
Table 2. Top five admission categories of patients managed in the resuscitation area of 
Khayelitsha Hospital, overall and according to HIV-status.  
Admission category  Overall 
n (%)  
HIV-positive 
n (%)  
HIV-negative 
n (%)  
p-value  
Intentional overdose  60 (16.2)  21 (14.8)  13 (8.7)  <0.01  
Respiratory  59 (15.9)  31 (21.8)  22 (14.6)  0.12  
Neurological  50 (13.5)  16 (11.3)  30 (20.0)  0.04  
Gastro-Intestinal  45 (12.2)  28 (19.7)  13 (8.7)  0.01  
Cardiovascular  42 (11.4)  12 (8.5)  21 (14.0)  0.14  
  
A total of 211 (57%) patients received a mobile chest x-ray, 167 (45.1%) had an 
electrocardiogram (ECG) and 73 (19.7%) had an ultrasound examination (Table 3). HIV-
positive patients were more likely to be investigated by an abdominal ultrasound (p<0.001). 
An HIV rapid test was performed on 57 (15.4%) patients and sputum investigations for 
tuberculosis done in 10 (2.7%) patients. The administration of intravenous antibiotics (n=141, 
38.1%) occurred significantly more in the HIV-positive group (Table 3).  
  
Table 3. Diagnostic tests and therapeutic interventions performed in patients managed in the 
resuscitation area of Khayelitsha Hospital.  
   Overall 
n (%)  
HIV  
Positive n 
(%)  
HIV  
Negative n 
(%)  
p- 
value  
Diagnostic test          
Mobile chest x-ray  211 (57.0)  90 (42.7)  105 (49.8)  0.23  
Electrocardiogram (ECG)  167 (45.1)  63 (9.6)  74 (44.3)  0.4  
Abdominal ultrasound (point-of-care or 
formal)  
73 (19.7)  42 (57.5)  20 (27.4)  <0.01  
Blood culture  70 (18.9)  44 (62.9)  20 (28.6)  0.41  
Therapeutic intervention          
Intravenous antibiotics  141 (38.1)  78 (55.3)  45 (31.9)  <0.01  
Intravenous potassium replacement  16 (4.3)  8 (50.0)  7 (43.75)  0.72  
Continuous positive airway pressure  16 (4.3)  2 (12.5)  9 (56.25)  0.04  
Intubation and ventilation  12 (3.2)  2 (16.7)  8 (66.7)  0.07  
Inotropes  8 (2.2)  3 (37.5)  2 (25.0)  0.75  
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Half of the patients (n=186, 50.3%) were subsequently managed by in-hospital specialist teams 
of which 84 (45.2%) were HIV-positive and 34 (18.3%) had active tuberculosis disease (Table 
4).   
  
  
Table 4. Disposition of patients from the resuscitation area of Khayelitsha Hospital.  
  Overall 
n (%)  
Active 
tuberculosis 
n (%)  
HIV  
positive 
n (%)  
HIV  
negative 
n (%)  
p-value  
(HIV  
status)  
Managed by emergency centre staff 
outside the resuscitation area  
101  
(27.3)  
1 (2)  29 (20.4)  37 (23.9)  0.48  
Referred to specialist services within 
Khayelitsha Hospital  
186  
(50.3)  
35 (70)  84 (59.2)  74 (47.7)  0.05  
Referred to tertiary facilities  63 (17.0)  11 (22)  23 (16.2)  30 (19.4)  0.48  
Died in resuscitation area  20 (5.4)  3 (6)  6 (4.2)  14 (9.0)  0.11  
  
370  
(100)  
50 (100)  142 (100)  155 (100)    
  
The in-hospital mortality during the study period was 17.0% (n=63). Twenty patients (31.7%) 
died in the resuscitation area, 28 patients (44.5%) with in-hospital teams at Khayelitsha 
Hospital and 15 patients (23.8%) who were referred to a tertiary facility. Neither HIV-status 
(p=0.27), nor tuberculosis status (p=0.27) were associated with all-cause in-hospital mortality. 
Overall, 16 (25.4%) deaths related to the respiratory system (pneumonia), 10 (15.9%) to the 
neurological system (cerebrovascular accidents, seizures, meningitis and hepatic 
encephalopathy), and 8 (12.7%) to each of the cardiovascular and gastrointestinal systems 
(including congestive cardiac failure and acute gastro-enteritis, respectively).  
Discussion  
This study describes the burden of tuberculosis and HIV on the resuscitation area of a district 
level hospital. HIV-positive patients place a unique burden on the resuscitation area of 
Khayelitsha Hospital with regards to intentional overdose and ultrasound examinations. The 
in-hospital mortality rate was high, but not associated with either HIV or tuberculosis status.  
Our study findings suggest that the HIV prevalence of patients attending the emergency centre 
is substantially higher than the provincial prevalence. This is in contrast to data from a district 
level emergency centre in KwaZulu-Natal, where the HIV prevalence of emergency admissions 
was similar to the provincial prevalence (emergency centre prevalence 44.4%; provincial 
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prevalence 49.7%).18 The HIV prevalence in our study (38%) was three times higher than the 
national HIV prevalence in 2016, despite the Western Cape having an HIV prevalence rate well 
below the national figure.4 However, Khayelitsha has the highest antenatal HIV prevalence in 
the Western Cape (34%).19 This would support a higher HIV prevalence in Khayelitsha than 
the rest of the Western Cape, despite taking into account that the antenatal HIV prevalence will 
be higher than the community prevalence as it reflects young sexually active females.  
Nevertheless, the prevalence most likely indicate that HIV infection does in fact result in a 
disproportionate increase in admissions compared to HIV negative status.  
The in-hospital mortality of medical patients presenting to the resuscitation area was 
substantially higher than trauma-related deaths from the same clinical area (17% versus 3%).14 
This is expected as the mortality rate in medical patients are usually higher than in other clinical 
disciplines.20 The in-hospital tuberculosis mortality rate (22%) was very similar to the national 
tuberculosis mortality rate of 21% in 2015,8 but substantially higher than the 6% of the Western 
Cape.7 Nonetheless, it was similar to the global tuberculosis in-hospital mortality amongst 
persons living with HIV of 27% in 2016.21 Neither HIV nor tuberculosis status correlated 
significantly with mortality, but our results may be confounded by the large proportion of 
patients that had an unknown tuberculosis and/or HIV status. More robust data regarding 
mortality rates in district level hospitals in South Africa is needed.  
Intentional overdose related presentations occurred frequently, especially in the HIV-positive 
group. This is in keeping with a recent study at Khayelitsha Hospital where a fifth of intentional 
overdose related presentations occurred in HIV-positive patients.12 Other African studies have 
shown a definite correlation between HIV/AIDS and suicidal ideation or attempt.22,23 
Associated factors seems to relate to the stigma of HIV/AIDS (e.g. feeling ashamed of status) 
as well as clinical factors such as a perception of poor physical health, physical pain, and being 
newly diagnosed.23 Investigating underlying reasons for selfharm attempts were beyond the 
scope of the study, but needs to get attention. Apart from the HIV burden, the people of 
Khayelitsha are faced with multiple psychosocial intricacies such as poverty, unemployment, 
incomplete schooling, and high rates of violence (interpersonal, domestic and sexual).24 It is 
therefore, not surprising that many patients encounter frustration and depression in such 
circumstances, and may contribute to suicidal ideation and depression.  
Point-of-care and formal ultrasound was used notably more in HIV-positive patients. The 
frequency of its use is considerably higher than data from a HIV-cohort presenting to an 
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emergency centre in KwaZulu/Natal.18 Ultrasound has been used to diagnose extra-pulmonary 
tuberculosis in mainly HIV positive patients,25–27 despite the lack of robust evidence for its use. 
Abdominal ultrasound had a pooled sensitivity of 63% and pooled specificity of 68% in 
diagnosing bacteriologically confirmed HIV associated tuberculosis; however the review 
reported very low quality evidence and only included one study evaluating point-of-care 
ultrasound.28 Issues encountered with point-of-care ultrasound in the emergency centre 
environment are that not all emergency doctors are proficiently trained in performing these 
investigations, which are operator dependant and may yield variable results depending on the 
user.29 Formal abdominal ultrasound is also subject to the availability of proficiently trained 
sonographers in an already burdened radiology department, where imaging often only happens 
the following day or when sonographers are available.  
Limitations  
Several factors may have influenced the results of this study. One of the major limitations in 
this study was the large number of patients with an unknown HIV and/or tuberculosis status; a 
reflection of the large proportion of untested individuals in a high prevalent area (both HIV and 
tuberculosis). It is thus possible that the prevalence of these diseases may therefore be 
underestimated, and not be a true reflection of the actual burden of disease. The statistical 
inference of the study’s results may also be biased due to the large number of missing variables, 
and, thus, acknowledged as such. It should also be noted that the study was confined to the 
resuscitation area and not all areas of emergency centre, and it is unclear what effect this will 
have on the actual disease burden on the emergency centre as a complete entity. Care should 
also be taken not to generalise the results of this study to other health districts, provinces or 
countries due to the small sample size and the unique population profile of Khayelitsha. Further 
studies of similar district level institutions, measuring similar parameters, would be needed in 
order to draw more objective conclusions to the initial research questions. Lastly, the actual 
causes of death were not analysed, and it remains unclear whether HIV and/or tuberculosis 
were just contributing factors or the actual cause of death.  
Conclusion  
This study highlights the influence of HIV and tuberculosis on the provision of acute care at a 
district level hospital. Despite this burden, the in-hospital mortality was not associated with 
either HIV or tuberculosis status indicating that the biggest impact on patient outcome seems 
to relate to the acuity of the presentation. The high prevalence of intentional overdose 
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presentations may speak to a larger underlying set of social vicissitudes which need to be 
addressed.  
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Abstract  
Background: HIV/AIDS and TB place a massive burden on South Africa's health services 
with many individuals  accessing  the  health  system  through  hospital  emergency  centres  
when  there  have  been delays to adequate diagnosis and treatment of infective complications 
(especially TB) in primary care settings. Patients presenting to emergency centres are often 
severely ill  and prompt  management  is needed  to  decrease  morbidity  and  mortality.[1]  
However,  the  burden  of  HIV  and  TB  in  emergency centres  in  South  Africa  is  not  well  
described,  particularly  in  the  era  of  widespread  antiretroviral therapy availability that would 
be expected to reduce hospital presentations.  
Objective: To determine the contemporary burden of HIV and TB on the resuscitation unit in 
the Emergency Centre of Khayelitsha Hospital.  
Methods: A retrospective chart review will be performed. Twelve randomly selected weeks 
from the Khayelitsha Hospital resuscitation database (a prospectively collected observational 
database capturing all patients managed within the resuscitation area since 1 November 2014) 
will be the sampled. Trauma cases will be excluded. Patients with missing information will 
only be excluded on the  sections  pertaining to that particular  variable.  We  foresee  a  sample  
size  of  about  350  patients. Variables to be collected are patient demographics (age / gender); 
patient acuity (according to the South African Triage Scale); TB and HIV infection status; CD4 
count; reason for admission to the resuscitation unit; diagnostic tests performed and their 
results; interventions received while in the resuscitation unit; time spent in the resuscitation 
unit; disposition from the resuscitation unit; and in- hospital outcome. Data will be categorized 
and analysed in four groups relating to the TB and HIV status. The outcomes are the prevalence 
of HIV and active TB in patients admitted to the resuscitation unit; the comparison between 
the above mentioned groups regarding in-hospital mortality.  
Conclusion: The rationale for this project lies in the fact that the burden of HIV- and TB-
related medical emergencies is mainly dictated by disease prevalence. Limited data on the 
contemporary prevalence of HIV and active TB in emergency centres is currently available. 
The knowledge gained from this project will have logistic, human resource and financial 
implications. Training and preventive measures may also be strengthened.  
    
38  
  
1.  Introduction 1.1.Background  
Tuberculosis  (TB)  and  Human  Immunodeficiency  Virus  (HIV)  are  deadly  communicable  
diseases, particularly  in  socio-economically  deprived  regions  of  the  world.  Despite  the  
advancement  of knowledge with regard to pathogenesis and treatment of these diseases over 
recent years, TB and HIV still pose a great health care burden on a global scale.  
An  estimated 36.9  million people  were living with HIV  at  the  end  of  2014, with around  2 
million people  becoming newly infected and approximately 1.2  million people having lost  
their  lives  from HIV related causes.[2]  Sub Saharan Africa accounts for almost 70% of the 
global total of new HIV infections  and  is  the  most  affected  region  with  25.8  million  
people  living  with  HIV  in  2014.[2]   In South Africa in 2012, an estimated 6.4 million people 
(12.2%) were HIV-infected; 1.2 million more than  
in 2008.[3]  
TB (pulmonary and extra-pulmonary) adds a similar burden. An estimated 9 million people 
developed TB globally in 2013.[4]  The African region of the World Health Organization (WHO) 
had the second highest  number  of  incident  cases  (2.6  million;  29%),  but  the  highest  
incidence  rate  (280  vs  126 globally) and mortality rate (42 vs 16 globally) per 100 000 
population.[4]  In 2013, South Africa had the 6th  largest absolute number of incident TB cases 
per country (between 410 000 and 520 000), but the 3rd  highest incidence rate (860 per 100 000 
population) in the world.[4]  
HIV/TB co-infection increases the burden even more. TB remains the leading cause of death 
among people living with HIV, accounting for  around one in five AIDS-related deaths.[5]  
However, this is likely an underestimation as many TB cases (~40%) are undiagnosed.[6]  More 
than one million people (13%)   diagnosed   worldwide   with  TB  in   2013   were   HIV   co-
infected.[4]    With   HIV   treatment advancements  and  growing  knowledge  among  healthcare  
workers  and  the  general  population,  TB related deaths among people living with HIV have 
declined by 36% worldwide from 2004 to 2013.[7] Despite  this  decline,  the  HIV-associated 
TB  endemic  still  has  high  morbidity  and  mortality  rates, especially in South Africa. In the 
Western Cape, HIV and TB were the 3rd (6%) and 4th  (5.7%) leading causes of death, 
respectively, at the end of 2013.[8]  
HIV infection is also associated with many other complications apart from TB and can involve 
any organ  system.  Serious  complications that  could be life-threatening relates to the  
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respiratory system (bacterial  pneumonia,  Pneumocystis  jiroveci  pneumonia),  the  cardiac  
system  (pericardial  disease, cardiomyopathy) and the neurological system (cryptococcal 
meningitis, toxoplasmosis).[9]  However, few  data  are  available  on  the  exact  impact  of  HIV  
and  TB  on  emergency  centres,  specifically resuscitation units, in South Africa.  
1.2.Rationale  
The  burden  of  HIV-  and  TB-related  medical  emergencies  is  dictated  by  disease  
prevalence,  the availability  of  treatment,  and  the  expertise  of  the  primary  health  system.  
The  rationale  for  this research  project  is  to  quantify  the  burden  of  HIV-and  TB-related  
emergencies  by  determining  the prevalence in the resuscitation unit of Khayelitsha Hospital.  
The prevalence of HIV-related cases in emergency centres in South Africa is largely unknown 
with only one single-centre study indicating a 50% HIV prevalence in medical patients.[10]  
Currently, there is no data on the burden of HIV on emergency centres in the Western Cape, 
although more than 50% of  medical  admissions  to  Khayelitsha  Hospital  are  HIV-related  
(Meintjes,  unpublished).  A  similar knowledge gap exists relating to TB in emergency centres. 
Almost 15% of presentations to the Paarl Hospital emergency centre were attributed to TB;[11]  
whereas 33% of unselected HIV-infected patients at G.F Jooste Hospital were diagnosed with 
TB on the first day of acute hospital admission.[12]  
Antiretroviral and anti-tuberculous treatment is available free of charge at government primary 
care clinics in South Africa but various problems still exists with stigma, diagnosis and 
treatment access. Reasons  for  this  range  from  ignorance  at  patient  and  healthcare  levels  
to  problems  related  to  the availability and accuracy of diagnostic tests. Co-infection with 
HIV further increases the diagnostic challenge, especially that of TB.[13]  
1.3.Significance  
HIV/AIDS and TB place a massive burden on South Africa's health services with many 
individuals accessing  the  health  system  through  hospital  emergency  centres  when  there  
have  been  delays  to adequate   diagnosis   and   treatment   of   infective   complications  
(especially  TB)   in   primary  care settings.[14]  Patients presenting to emergency centres are 
often severely ill and prompt management is needed  to  decrease  morbidity  and  mortality.[1]  
However,  the  burden  of  HIV  and  TB  in  emergency centres  remains  largely  unquantified.  
The  knowledge  gained  from  this  project  will  have  logistic, human   resource   and   financial   
implications.   Training   and   preventive   measures   will   also   be strengthened.  
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1.4.Research Question  
What is the burden of HIV and TB on the resuscitation unit of Khayelitsha Hospital?  
  
1.5.Aim and objectives  
The aim of the study is to determine the contemporary burden of HIV and TB on the 
resuscitation unit in the Emergency Centre of Khayelitsha Hospital  
  
The objectives are:  
• To determine the prevalence of HIV and TB in patients presenting to the resuscitation 
unit of Khayelitsha Hospital  
• To determine   the   in-hospital   mortality   of   patients   with   HIV   and   TB   
presenting   the resuscitation unit of Khayelitsha Hospital  
• To compare the in-hospital mortality of patients with HIV and TB to those without HIV 
and TB  
  
2.  Methodology 2.1.Study Design  
A  retrospective  analysis  of  a  prospectively  collected  observational  database  combined  
with  a retrospective chart review to include additional variables.  
2.2.Study Setting  
Khayelitsha Hospital is a 240 bed hospital in the constantly expanding township of Khayelitsha, 
Cape  
Town. It  serves a health district  with a population of more than 390 000, which are 
predominantly black African (99%).[15]  The community is also faced with high levels of 
unemployment (38%), with a high disease burden of TB, HIV, and interpersonal violence.[15]  
Khayelitsha  Hospital  provides  inpatient  services  to  the  community  such  as  medical,  
surgical, paediatric and obstetric, with an emergency centre 30% larger than for a standard 
district hospital in South  Africa.[15,  16]   The  resuscitation  unit  consists  of  four  adult  beds  
and  one  paediatric  cot,  each equipped with its own monitor (blood pressure, pulse oximetry, 
and capnography capabilities) and a stand-alone ventilator. A fully stocked emergency trolley 
for airway management with a defibrillator is also available. The main admission criteria to the 
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resuscitation unit is a high acuity score, according to the South African Triage Scale (SATS).[17]  
The SATS takes into account vital sign parameters such as  heart  rate,  respiratory  rate,  blood  
pressure  and  temperature  and  group  patients  into  colour  code categories. The colour codes 
suggest the urgency of the presenting complaints and recommend a time frame in which the 
patients should be assessed by a medical practitioner.[17]  Alternatively a patient can be managed 
in the resuscitation unit at the discretion of any senior practitioner on duty  
2.3.Study Population  
The electronic Khayelitsha Hospital resuscitation database is a prospectively collected 
observational database capturing all patients managed within the resuscitation area since 1 
November 2014. Data are captured electronically via a tailored smartphone application, are 
immediately coded and directly stored onto a password protected server. A decoding sheet is 
separately stored. The guarantor of the database (Dr van Hoving) also ensures that the clinical 
notes of captured patients are available on the Khayelitsha  Hospital  ECM (Enterprise  Content  
Management)  system (current  capture rate ±  95%).  
The main study has been registered at the Stellenbosch University Health Research Ethics 
Committee (Ref: N14/08/102 with amendment 24 June 2015) as well as at the National Health 
Research Database (Ref: WC_2014RP10_967).  
We will randomly select 12 weeks from the Khayelitsha Hospital resuscitation database. A 
computer- based  random  number  generator  will  be  used.  All  patients  admitted  during  
these  weeks  will  be eligible for  inclusion, but  trauma-related cases will  be excluded (HIV  
is not  a cause of trauma but incidental). Patients with missing information will only be 
excluded from analysis for those variables where information is missing.  
We  foresee  a  sample  size  of  about  350  patients. This  correlates  to  an  estimated  true  
proportion  of 35%, a 10% confidence interval width and a desired precision of 5%.   
2.4.Data Collection and Management  
Data  will  be  collected  by the  investigators  on  site  at  Khayelitsha  Hospital  after a  decoded 
cleaned extract of the resuscitation database has been obtained (cleaned: copied into an Excel 
spreadsheet with all  trauma  cases  removed).  The  Excel  spreadsheet  will  then  be  further  
populated  through  the electronic  clinical  record,  the  National  Health  Laboratory  Service  
web  view,  and  the  Clinicom information system. The following variables will be collected:  
• Patient demographics (Age / Gender)  
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• Patient acuity (according to the South African Triage Scale)  
• TB status (active TB or not)  
• HIV infection status  
• CD4 lymphocyte count if HIV-infected  
• Reason for admission to the resuscitation unit  
• Diagnostic tests performed  
• Interventions received while in the resuscitation unit  
• Time spent in the resuscitation unit  
• Disposition from the resuscitation unit  
• In-hospital mortality  
  
Data will be entered onto a password protected Microsoft Excel®  spreadsheet. The data will be 
stored on a password-protected computer, with a back-up copy on an external hard drive stored 
in a lockable cupboard in the Division of Emergency Medicine office, Stellenbosch University. 
Access to the data will be limited to the research team.  
Data will be categorized into four nominal input variables:  
• Group A = No active TB & HIV negative  
• Group B = No active TB & HIV positive  
• Group C = Active TB & HIV negative  
• Group D = Active TB & HIV positive  
  
An HIV positive case is defined as a laboratory confirmed HIV result (either prior to admission 
or during the admission). Patients with unknown HIV  status will  be reported as such, but two 
sets of analyses will be done; one excluding them and one including them with HIV negatives. 
An active TB case is defined as a laboratory confirmed result from any sample during the 
current admission or six months  prior  to  admission,  or  patients  who  have  been  empirically  
diagnosed  with  active  TB  and started on TB treatment. 2.5.Data Analysis  
Summary statistics will be used to describe all variables. Distributions of variables will be 
presented with histograms and or frequency tables. Medians or means will be used as the 
measures of central location for ordinal and continuous responses and standard deviations and 
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quartiles as indicators of spread. The prevalence of HIV, TB and TB/HIV co-infection will be 
calculated using the total number of patients in the sample as the denominator.  
The  relationships  between  the  continuous  variables  will  be  analysed  using  appropriate  
analysis  of variance  (ANOVA)  tests  or  the  Kruskal-Wallis  test  if  the  data  do  not  meet  
the  requirements  for  a parametric test. The Chi-square test will be used when categorical 
variables are compared. A 5% level of confidence will be used to determine significance.  
Analysis will be duplicated. The first analysis will be done with the HIV-unknown cases 
excluded and then repeated with HIV-unknown cases categorised as HIV negative.  
Data analysis will be done by the principal investigator with support from the supervisor using 
SPSS (version 22.0).  
2.6.Time Schedule  
• March 2016: Ethics and institutional approval  
• April 2016 - June 2016: Data collection  
• July 2016  - August 2016: Data analysis  
• September 2016 - January 2017: Writing up and submission  
3.  Ethical Considerations  
Risks  and  benefits:  As  this  study  will  not  involve  direct  or  indirect  patient  care,  risk  to  
patients  is likely minimal. The electronic resuscitation database is already part of another study 
project and has passed through an ethics committee in the process. Potential risk due to loss of 
patient data is however possible. For this reason identifying information will be removed as 
soon as the data collection for that specific patient is completed. Having a better idea of the 
specific burden related to HIV and TB at a district-level hospital may lead to improved 
emergency centre practices and resource allocation.  
Informed consent process: The database from which the initial data will be drawn is registered 
with the  
Stellenbosch University Health Research Ethics Committee (Ref: N14/08/102) as well as on 
the National  Health Research Database (Ref: WC_2014RP10_967). The information obtained 
from the database will be supplemented with review of the patient record. As this will be 
retrospective, taking individual consent will be impractical.  
Privacy  and  confidentiality:  As  described  earlier,  the  study  will  make  use  of  a  
combination  of safeguards to ensure anonymity of study subjects. This will include on-site 
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data management using a Western Cape Government account and computers, a password 
protected Excel document containing the  data  sample,  and  coding  data  immediately  after  
data  collection  is  completed  and  removing identifying information.  
As  this  is  a  retrospective  study  with  no  personal  patient  information  being  accessed,  
utilised  or divulged, a waiver of informed consent is requested.  
4.  Limitations  
This  is  a  retrospective  study  using  an  existing  database  and  therefor  has  inherent  risks  
of  error. Selection bias is primarily a result of either inappropriate inclusion or exclusion of 
subjects into the database or due to missing data. Inclusion criteria for the Khayelitsha 
Resuscitation database is well defined and should not lead to a significant error.  
Missing data allow for selection bias by allowing preference for study subjects with complete 
data. Patients  with  missing  data  will  be  reported  and  will  not  be  excluded  from  analysis;  
only  the incomplete data points will be excluded. Missing patients from the database is also 
limited since the database  manager  regularly  does  quality  checks  to  ensure  all  patients  
are  captured.  The  Clinicom Hospital Information System, the ECM system and the 
resuscitation unit nursing register is used for this.  
Data entered into the database may also be imprecise or invalid, resulting in information bias. 
This is again limited by the quality control performed by the database manager.  
5.  Reporting and implementation of results  
Publication  as  an  original  article  or  short  report  in  a  peer  reviewed  journal  is  anticipated.  
The study  results  will  also  be  distributed  to  the  management  team  of  Khayelitsha  Hospital  
Emergency Centre  and  hospital  administration.  We  will  also  prepare  a  policy  brief  for  
the  provincial  Health Impact Assessment Unit.  
6.  Resources 6.1.Resources utilisation  
Resources  used  will  be  mainly  non-clinical.  This  will  include  use  of  an  existing  Western  
Cape Government  account  and  computers.  As  most  patient  information  will  be  
electronically  available, Khayelitsha Hospital clerks will not be utilised to access hard copy 
folders. The investigators will not conduct the study when on-duty.  
6.2.Budget  
The budget for this study is: R 3250  
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2. Ethics approval  
  
Approved with Stipulations  
New Application  
26-Nov-2015  
Mentoor, Lynne L  
Ethics Reference #: S15/10/243  
Title: The burden of HIV and TB on the resuscitation unit of Khayelitsha Hospital.  
Dear Dr Lynne Mentoor,  
The New Application received on 27-Oct-2015, was reviewed by members of Health 
Research Ethics Committee 2 via Expedited review procedures on 11-Nov-2015.  
Please note the following information about your approved research protocol:  
Protocol Approval Period: 24-Nov-2015 -24-Nov-2016  
The Stipulations of your ethics approval are as follows:  
1. A waiver of informed consent is approved on the condition that at the point of 
data entry all data will be completely anonymised andaggregated.  
2. HREC would like to alert the supervisor, Dr DJ van Hoving, that if there are 
plans moving forward to continue to access this database fromN14/08/102 for research 
purposes, that the database should be registered as such through an application to the 
HREC for the establishment of a database for research purposes.  
Please remember to use your protocol number (S15/10/243) on any documents or 
correspondence with the HREC concerning your research protocol.  
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Please note that the HREC has the prerogative and authority to ask further questions, seek 
additional information, require further modifications, or monitor the conduct of your research 
and the consent process.  
After Ethical Review:  
Please note a template of the progress report is obtainable on www.sun.ac.za/rds and should be 
submitted to the Committee before the year has expired. The Committee will then consider the 
continuation of the project for a further year (if necessary). Annually a number of projects may 
be selected randomly for an external audit.  
Translation of the consent document to the language applicable to the study participants should 
be submitted.  
Federal Wide Assurance Number: 00001372  
Institutional Review Board (IRB) Number: IRB0005239  
The Health Research Ethics Committee complies with the SA National Health Act No.61 2003 
as it pertains to health research and the United States  
Code of Federal Regulations Title 45 Part 46. This committee abides by the ethical norms and 
principles for research, established by the Declaration of  
Helsinki, the South African Medical Research Council Guidelines as well as the Guidelines for 
Ethical Research: Principles Structures and Processes 2004 (Department of Health).  
Provincial and City of Cape Town Approval  
Please note that for research at a primary or secondary healthcare facility permission must still 
be obtained from the relevant authorities (Western Cape Department of Health and/or City 
Health) to conduct the research as stated in the protocol. Contact persons are Ms Claudette 
Abrahams at Western  
Cape Department of Health (healthres@pgwc.gov.za Tel: +27 21 483 9907) and Dr Helene 
Visser at City Health (Helene.Visser@capetown.gov.za Tel: +27 21 400 3981). Research that 
will be conducted at any tertiary academic institution requires approval from the relevant 
hospital manager. Ethics approval is required BEFORE approval can be obtained from these 
health authorities.  
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We wish you the best as you conduct your research.  
For standard HREC forms and documents please visit: www.sun.ac.za/rds  
If you have any questions or need further assistance, please contact the HREC office at 
219389819.  
Included Documents:  
CV D van Hoving  
Application form  
Declaration L Swarts  
CV L Swarts  
Protocol  
Declaration D van Hoving  
Protocol Synopsis  
Waiver of informed consent request  
Checklist  
Sincerely,  
Ashleen Fortuin  
HREC Coordinator  
Health Research Ethics Committee 2    
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Investigator Responsibilities  
Protection of Human Research Participants  
Some of the responsibilities investigators have when conducting research involving human 
participants are listed below:  
1.Conducting the Research. You are responsible for making sure that the research is conducted 
according to the HREC approved research protocol. You are also responsible for the actions of 
all your coinvestigators and research staff involved with this research.  
2.Participant Enrolment. You may not recruit or enrol participants prior to the HREC approval 
date or after the expiration date of HREC approval. All recruitment materials for any form of 
media must be approved by the HREC prior to their use. If you need to recruit more participants 
than was noted in your HREC approval letter, you must submit an amendment requesting an 
increase in the number of participants.  
3.Informed Consent. You are responsible for obtaining and documenting effective informed 
consent using only the HREC-approved consent documents, and for ensuring that no human 
participants are involved in research prior to obtaining their informed consent. Please give all 
participants copies of the signed informed consent documents. Keep the originals in your 
secured research files for at least fifteen (15) years.  
4.Continuing Review. The HREC must review and approve all HREC-approved research 
protocols at intervals appropriate to the degree of risk but not less than once per year. There is 
no grace period. Prior to the date on which the HREC approval of the research expires, it is 
your responsibility to submit the continuing review report in a timely fashion to ensure a 
lapse in HREC approval does not occur. If HREC approval of your research lapses, you must 
stop new participant enrolment, and contact the HREC office immediately.  
5.Amendments and Changes. If you wish to amend or change any aspect of your research (such 
as research design, interventions or procedures, number of participants, participant population, 
informed consent document, instruments, surveys or recruiting material), you must submit the 
amendment to the HREC for review using the current Amendment Form. You may not initiate 
any amendments or changes to your research without first obtaining written HREC review and 
approval. The only exception is when it is necessary to eliminate apparent immediate hazards 
to participants and the HREC should be immediately informed of this necessity.  
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6.Adverse or Unanticipated Events. Any serious adverse events, participant complaints, and all 
unanticipated problems that involve risks to participants or others, as well as any research-
related injuries, occurring at this institution or at other performance sites must be reported to 
the HREC within five (5) days of discovery of the incident. You must also report any instances 
of serious or continuing problems, or non-compliance with the HRECs requirements for 
protecting human research participants. The only exception to this policy is that the death of a 
research participant must be reported in accordance with the Stellenbosch University Health 
Research Ethics Committee Standard Operating Procedures www.sun025.sun.ac.za/portal  
/page/portal/Health_Sciences/English/Centres%20and%20Institutions/Research_Developme
nt_Suppor t/Ethics/Application_package All reportable events should be submitted to the 
HREC using the Serious Adverse Event Report Form.  
7.Research Record Keeping. You must keep the following research-related records, at a 
minimum, in a secure location for a minimum of fifteen years: the HREC approved research 
protocol and all amendments; all informed consent documents; recruiting materials; continuing 
review reports; adverse or unanticipated events; and all correspondence from the HREC  
8.Reports to the MCC and Sponsor. When you submit the required annual report to the MCC 
or you submit required reports to your sponsor, you must provide a copy of that report to the 
HREC. You may submit the report at the time of continuing HREC review.  
9.Provision of Emergency Medical Care. When a physician provides emergency medical care 
to a participant without prior HREC review and approval, to the extent permitted by law, such 
activities will not be recognised as research nor will the data obtained by any such activities 
should it be used in support of research.  
10.Final reports. When you have completed (no further participant enrolment, interactions, 
interventions or data analysis) or stopped work on your research, you must submit a Final 
Report to the HREC.  
11.On-Site Evaluations, MCC Inspections, or Audits. If you are notified that your research will 
be reviewed or audited by the MCC, the sponsor, any other external agency or any internal 
group, you must inform the HREC immediately of the impending audit/evaluation.  
  
    
53  
  
3. Author Guidelines: African Journal of Emergency Medicine  
  
The instructions to authors are available from http://cdn.elsevier.com/promis_misc/AfJEM-GFA.pdf  
